The evidence strongly suggests that EVOO, particularly high-polyphenol varieties, supports metabolic health through multiple converging mechanisms: enhanced GLP-1 and PYY secretion, improved insulin sensitivity, reduced inflammation, and modulation of gut permeability
Furthermore, NAC affects various neurotransmitter systemsincluding glutamatergic, dopaminergic, GABAergic, serotonergic, cholinergic, and adrenergic pathwaysby modulating synaptic transmission, receptor activity, and transporter functionality
For established scars more than 6 months old, evening application alone is sufficient
By targeting both GIP and GLP-1 receptors, tirzepatide helps control appetite and food intake while also improving glycemic control